9621 Agnes Crossing, Lake Suzanneview, New Mexico Island 84604-9295.
COVID-19, which broke out in 2019 and quickly caused a long-lasting pandemic and killed millions of people around the world, is considered by many to be one of
COVID-19, which broke out in 2019 and quickly caused a long-lasting pandemic and killed millions of people around the world, is considered by many to be one of the most devastating diseases of recent years. Although effective medicines have been developed for this virus in a short time, COVID-19 is still seriously showing its effects in many parts of the world.
With the rapid development of technology and artificial intelligence in recent years, the health sector has started accelerating its efforts to take advantage of the power of artificial intelligence. Hong Kong-based pharmaceutical company Insilico Medicine has already done so It has already produced the first COVID-19 vaccine developed using artificial intelligence.
Insilico Medicine, whose founders are Canadian but based in Hong Kong, has announced that they have produced the most effective and “near-perfect” COVID-19 vaccine to date, with the support of an artificial intelligence model developed specifically for the health sector. Alex Zhavoronkov, the founder of Insilico, stated that thanks to artificial intelligence, they completed lab tests that normally take months in just a few days. “in determining which enzymes the drug will target” played a crucial role and in the simulations made in the lab environment, the drug was found to be much more effective than expected.
Insilico’s new COVID-19 vaccine binds enzymes in the virus, known as proteases, so that these enzymes cannot affect the human body. Former Oxford University President Dr Peter Juni on Insilico’s New Drug”I think the target of the drug is great. Because the targeted proteases are different from the proteases found in the human body and so it is almost impossible for the drug to harm the body by targeting the wrong proteases.He stated that the drug can be effective and reliable.
While Insilico researchers refrained from commenting on the artificial intelligence used in the production of this vaccine, they announced that the first clinical trials will begin next Thursday with laboratories in China.
Source: Web Tekno
Alice Smith is a seasoned journalist and writer for Div Bracket. She has a keen sense of what’s important and is always on top of the latest trends. Alice provides in-depth coverage of the most talked-about news stories, delivering insightful and thought-provoking articles that keep her readers informed and engaged.
:quality(85)//cloudfront-us-east-1.images.arcpublishing.com/infobae/RXKEVF22NFCQBIKSH5AWOCJOY4.jpg "Why you should learn cloud computing before entering university")
